HealthStream Inc Executive Vice President Michael Sousa Sells 15,000 Shares

In this article:

On February 26, 2024, Executive Vice President Michael Sousa sold 15,000 shares of HealthStream Inc (NASDAQ:HSTM), as reported in a recent SEC Filing. Over the past year, the insider has sold a total of 15,000 shares and has not made any purchases of the company's stock.

HealthStream Inc is a company that specializes in workforce and provider solutions for the healthcare industry. The company's solutions are used by healthcare organizations to meet their training, certification, and development needs, as well as to manage their workforce and support patient outcomes.

The insider transaction history for HealthStream Inc indicates a lack of insider purchases over the past year, with 0 buys recorded. In contrast, there have been 3 insider sells during the same period, suggesting a trend of insider sales.

HealthStream Inc Executive Vice President Michael Sousa Sells 15,000 Shares
HealthStream Inc Executive Vice President Michael Sousa Sells 15,000 Shares

On the date of the insider's recent sale, shares of HealthStream Inc were trading at $27.25 each, giving the company a market capitalization of $831.635 million. The price-earnings ratio of the stock stands at 54.92, which is above the industry median of 26.92 but below the company's historical median price-earnings ratio.

According to the GF Value, with a share price of $27.25 and a GuruFocus Value of $26.68, HealthStream Inc has a price-to-GF-Value ratio of 1.02, indicating that the stock is Fairly Valued.

HealthStream Inc Executive Vice President Michael Sousa Sells 15,000 Shares
HealthStream Inc Executive Vice President Michael Sousa Sells 15,000 Shares

The GF Value is calculated based on historical trading multiples, a GuruFocus adjustment factor related to the company's past performance, and future business performance estimates provided by Morningstar analysts.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

This article first appeared on GuruFocus.

Advertisement